China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Q1 2025 Earnings Conference Call February 5, 2025 8:30 AM ETCompany ParticipantsYvonne Perron - Vice President, FP&A ...

The rising adoption of Sanger sequencing for mutation detection and confirmation ... diagnostic accuracy for individuals with various genetic disorders. .In June 2023, Illumina, Inc. introduced ...

Azenta Inc (AZTA) reports a 4% organic revenue increase and a robust cash position, while navigating market uncertainties and ...

(Illumina, San Diego, CA). Four patients were sequenced in each run, including paired DNA and RNA. Mutations found by NGS with VAF>15% were confirmed by Sanger sequencing and fusions detected by the ...

The average insert size for the final cDNA library was 300 ± 50 bp. At last, we performed the 2 × 150 bp paired-end sequencing (PE150) on an Illumina Novaseq™ 6000 (LC-Bio Technology CO., Ltd., ...

Illumina is down 15.2% since the beginning of the year, and at $111.06 per share, it is trading 28.4% below its 52-week high of $155.15 from November 2024. Investors who bought $1,000 worth of ...

Illumina has struggled to boost sales and consistently deliver positive earnings. Its Q4 report was largely a disappointment, and management's 2025 guidance came in below Wall Street's ...

China's "blacklist of entities" now has two more entries -- Illumina and fashion conglomerate PVH-- after its government put the companies on notice late Monday. The move is clearly a retaliatory ...